# Molecular-Docking-of-Roscovitine
This project investigates the molecular docking of **Roscovitine**, a cyclin-dependent kinase (CDK) inhibitor, with **CDK2** and **CDK5**, which are key regulators of the cell cycle and potential drug targets for cancer and neurodegenerative diseases.
